Premium
Ibrutinib is a safe and effective therapy for systemic mantle cell lymphoma with central nervous system involvement – a multi‐centre case series from the United Kingdom
Author(s) -
Tucker David L.,
Naylor Georgina,
Kruger Anton,
Hamilton Malcolm S.,
Follows George,
Rule Simon A.
Publication year - 2017
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.14122
Subject(s) - ibrutinib , mantle cell lymphoma , medicine , oncology , tolerability , diffuse large b cell lymphoma , lymphoma , adverse effect , leukemia , chronic lymphocytic leukemia
This article is currently freely available from the publisher's site (May 2016). Click on the 'Additional Link' above to access the full-text from the publisher's site
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom